Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

Xiang Ling, Diane Calinski, Asher A. Chanan-Khan, Muxiang Zhou, Fengzhi Li

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types'. Together they form a unique fingerprint.

Medicine & Life Sciences